RAMM Pharma

RAMM Pharma Earnings Yield

The Earnings Yield of RAMM Pharma (RAMM.CN) as of Oct 23, 2026 is -497.53 %. In the previous year, Earnings Yield was -921.48 % — a change of -46.01% (higher).

Earnings Yield

-497.53 %

YoY

-46.01%

Last updated:

Earnings Yield of RAMM Pharma is 2025 -497.53 % . Earnings Yield of RAMM Pharma was 2024 -921.48 % . It decreases by -46.01% higher compared to the previous year.

The RAMM Pharma Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2018
-38.23 CAD
Jan 1, 2019
-380.85 CAD
Jan 1, 2020
-414.92 CAD
Jan 1, 2021
-396.84 CAD
Jan 1, 2022
-1,170.40 CAD
Jan 1, 2023
-431.13 CAD
Jan 1, 2024
-921.48 CAD
Jan 1, 2025
-497.53 CAD
The RAMM Pharma Earnings Yield history
YEAREarnings YieldYoY
-497.53 %-46.01%
-921.48 %+113.73%
-431.13 %-63.16%
-1,170.40 %+194.93%
-396.84 %-4.36%
-414.92 %+8.95%
-380.85 %+896.29%
-38.23 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RAMM Pharma Stock analysis

What does RAMM Pharma do? RAMM Pharma Corp generates revenue through cannabinoid pharmaceuticals and cannabis-based products, with brands like NettaLife, NettaPet, NettaPet Senior, NettaPet Puppies, and NettaVet targeting pet owners and veterinary markets. The company also sells cosmetics under the Cannabipiel line, including Cannabipiel Nite, Cannabipiel Body Lotion, and Cannabipiel Shampoo, catering to consumers seeking cannabinoid-infused skincare and personal care solutions. Subsidiaries such as Canapar Corp. and Medic Plast SA support production and commercialization across pharmaceutical specialties, household products, and food sectors. The firm’s product portfolio spans pharmaceuticals, pet care, cosmetics, and household items, with NettaPet and NettaVet focusing on animal health and Cannabipiel products targeting human skincare. Revenue streams include direct sales of branded items like Cannabipiel Tite and Cannabipiel Cleaning Emulsion to retail and specialty markets, while subsidiaries handle manufacturing and export operations for global distribution. Brands like Glediser SA and Yurelan SA contribute to the commercialization of diverse product categories under the company’s umbrella. RAMM Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RAMM Pharma stock

Earnings Yield of RAMM Pharma is -497.53 % in 2025.

Earnings Yield of RAMM Pharma changed from -921.48 % to -497.53 %, representing a -46.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield RAMM Pharma since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's RAMM Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — RAMM Pharma

All Key Metrics — RAMM Pharma